Investigating Neurocognitive Disorders Epidemiology

RecruitingOBSERVATIONAL
Enrollment

990

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

August 24, 2035

Study Completion Date

August 24, 2035

Conditions
DementiaCognitive DeclineAlzheimer Disease
Interventions
DIAGNOSTIC_TEST

Plasma tau phosphorylated at Thr217

Plasma concentration of tau protein phosphorylated at Thr217 as measured on the Meso Scale Discovery, single molecule array (Simoa) or the in-house mass spectrometry platform.

OTHER

Neurocognitive examination

Traditional (paper and pencil) neurocognitive/neuropsychiatric examination performed by certified psychologists. This includes: Mini Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Clinical Dementia Rating (CDR), Wechsler Memory Scale - Fourth Edition (WMS-IV), Neuropsychiatric Inventory - Questionnaire (NPI-Q), Thai Geriatric Depression Scale (TGDS), General Anxiety Disorder - 7 (GAD-7), The Barthel activities of daily living (ADL) Index, Chula ADL Index.

Trial Locations (1)

10330

RECRUITING

King Chulalongkorn Memorial Hospital, Pathum Wan

All Listed Sponsors
collaborator

Health Systems Research Institute,Thailand

OTHER_GOV

lead

King Chulalongkorn Memorial Hospital

OTHER